{"pmid":32474039,"title":"Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19.","text":["Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19.","J Infect","Nguyen, Yann","Corre, Felix","Honsel, Vasco","Curac, Sonja","Zarrouk, Virginie","Fantin, Bruno","Galy, Adrien","32474039"],"journal":"J Infect","authors":["Nguyen, Yann","Corre, Felix","Honsel, Vasco","Curac, Sonja","Zarrouk, Virginie","Fantin, Bruno","Galy, Adrien"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474039","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.jinf.2020.05.049","keywords":["covid-19","curb-65","outpatient care","risk factor"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1668341932689981440,"score":9.490897,"similar":[{"pmid":32360857,"title":"Hidradenitis suppurativa: the importance of virtual outpatient care during COVID-19 pandemic.","text":["Hidradenitis suppurativa: the importance of virtual outpatient care during COVID-19 pandemic.","J Am Acad Dermatol","Shah, Monica","Naik, Haley B","Alhusayen, Raed","32360857"],"journal":"J Am Acad Dermatol","authors":["Shah, Monica","Naik, Haley B","Alhusayen, Raed"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32360857","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jaad.2020.04.142","keywords":["covid-19","coronavirus","emergency department","hidradenitis suppurativa","operational strategies","outpatient care","telemedicine"],"topics":["Prevention"],"weight":1,"_version_":1666138495570149377,"score":72.499084},{"pmid":32469137,"title":"A novel simple scoring model for predicting severity of patients with SARS-CoV-2 infection.","text":["A novel simple scoring model for predicting severity of patients with SARS-CoV-2 infection.","An outbreak of pneumonia caused by a novel coronavirus (COVID-19) began in Wuhan, China in December 2019 and quickly spread throughout the country and world. An efficient and convenient method based on clinical characteristics was needed to evaluate the potential deterioration in patients. We aimed to develop a simple and practical risk scoring system to predict the severity of COVID-19 patients on admission. We retrospectively investigated the clinical information of confirmed COVID-19 patients from February 10, 2020 to February 29, 2020 in Wuhan Union Hospital. Predictors of severity were identified by univariate and multivariate logistic regression analysis. A total of 147 patients with confirmed SARS-CoV-2 infection were grouped into non-severe (94 patients) and severe (53 patients) groups. We found that an increased level of white blood cells (WBC), neutrophils, D-dimer, fibrinogen (FIB), IL-6, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), alanine aminotransferase (ALT), aspartate aminotransferase (AST), alpha-hydroxybutyrate dehydrogenase (HBDH), serum amyloid A (SAA) and a decreased level of lymphocytes were important risk factors associated with severity. Furthermore, three variables were used to formulate a clinical risk scoring system named COVID-19 index = 3xD-dimer (microg/L)+2xlgESR (mm/h)-4xlymphocyte (x10(9) /L)+8. The area under the receiver operating characteristic (ROC) curve was 0.843 (95% CI, 0.771-0.914). We propose an effective scoring system to predict the severity of COVID-19 patients. This simple prediction model may provide health-care workers with a practical method and could positively impact decision-making with regard to deteriorating patients.","Transbound Emerg Dis","Dong, Yalan","Zhou, Haifeng","Li, Mingyue","Zhang, Zili","Guo, Weina","Yu, Ting","Gui, Yang","Wang, Quansheng","Zhao, Lei","Luo, Shanshan","Fan, Heng","Hu, Desheng","32469137"],"abstract":["An outbreak of pneumonia caused by a novel coronavirus (COVID-19) began in Wuhan, China in December 2019 and quickly spread throughout the country and world. An efficient and convenient method based on clinical characteristics was needed to evaluate the potential deterioration in patients. We aimed to develop a simple and practical risk scoring system to predict the severity of COVID-19 patients on admission. We retrospectively investigated the clinical information of confirmed COVID-19 patients from February 10, 2020 to February 29, 2020 in Wuhan Union Hospital. Predictors of severity were identified by univariate and multivariate logistic regression analysis. A total of 147 patients with confirmed SARS-CoV-2 infection were grouped into non-severe (94 patients) and severe (53 patients) groups. We found that an increased level of white blood cells (WBC), neutrophils, D-dimer, fibrinogen (FIB), IL-6, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), alanine aminotransferase (ALT), aspartate aminotransferase (AST), alpha-hydroxybutyrate dehydrogenase (HBDH), serum amyloid A (SAA) and a decreased level of lymphocytes were important risk factors associated with severity. Furthermore, three variables were used to formulate a clinical risk scoring system named COVID-19 index = 3xD-dimer (microg/L)+2xlgESR (mm/h)-4xlymphocyte (x10(9) /L)+8. The area under the receiver operating characteristic (ROC) curve was 0.843 (95% CI, 0.771-0.914). We propose an effective scoring system to predict the severity of COVID-19 patients. This simple prediction model may provide health-care workers with a practical method and could positively impact decision-making with regard to deteriorating patients."],"journal":"Transbound Emerg Dis","authors":["Dong, Yalan","Zhou, Haifeng","Li, Mingyue","Zhang, Zili","Guo, Weina","Yu, Ting","Gui, Yang","Wang, Quansheng","Zhao, Lei","Luo, Shanshan","Fan, Heng","Hu, Desheng"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32469137","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/tbed.13651","keywords":["covid-19","predict","risk factor","sars-cov-2","score model"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1668420887221633024,"score":68.32036},{"pmid":32389785,"title":"Comparison of CRB-65 and quick sepsis-related organ failure assessment for predicting the need for intensive respiratory or vasopressor support in patients with COVID-19.","text":["Comparison of CRB-65 and quick sepsis-related organ failure assessment for predicting the need for intensive respiratory or vasopressor support in patients with COVID-19.","J Infect","Su, Ying","Tu, Guo-Wei","Ju, Min-Jie","Yu, Shen-Ji","Zheng, Ji-Li","Ma, Guo-Guang","Liu, Kai","Ma, Jie-Fei","Yu, Kai-Huan","Xue, Yuan","Luo, Zhe","32389785"],"journal":"J Infect","authors":["Su, Ying","Tu, Guo-Wei","Ju, Min-Jie","Yu, Shen-Ji","Zheng, Ji-Li","Ma, Guo-Guang","Liu, Kai","Ma, Jie-Fei","Yu, Kai-Huan","Xue, Yuan","Luo, Zhe"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389785","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jinf.2020.05.007","keywords":["covid-19","crb-65","curb-65","community-acquired pneumonia","qsofa"],"topics":["Diagnosis"],"weight":1,"_version_":1666528580142628864,"score":63.957573},{"pmid":32407459,"title":"Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis.","text":["Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis.","The coronavirus disease 2019 (COVID-19) pandemic spread globally in the beginning of 2020. At present, predictors of severe disease and the efficacy of different treatments are not well-understood. We conducted a systematic review and meta-analysis of all published studies up to March 15, 2020 which reported COVID-19 clinical features and/or treatment outcomes. 45 studies reporting 4203 patients were included. Pooled rates of intensive care unit (ICU) admission, mortality and acute respiratory distress syndrome (ARDS) were 10.9%, 4.3% and 18.4%, respectively. On meta-regression, ICU admission was predicted by raised leukocyte count (p<0.0001), raised alanine aminotransferase (p=0.024), raised aspartate transaminase (p=0.0040), elevated lactate dehydrogenase (LDH) (p<0.0001) and increased procalcitonin (p<0.0001). ARDS was predicted by elevated LDH (p<0.0001), while mortality was predicted by raised leukocyte count (p=0.0005) and elevated LDH (p<0.0001). Treatment with lopinavir-ritonavir showed no significant benefit in mortality and ARDS rates. Corticosteroids were associated with a higher rate of ARDS (p=0.0003).","Clin Infect Dis","Zhang, John J Y","Lee, Keng Siang","Ang, Li Wei","Leo, Yee Sin","Young, Barnaby Edward","32407459"],"abstract":["The coronavirus disease 2019 (COVID-19) pandemic spread globally in the beginning of 2020. At present, predictors of severe disease and the efficacy of different treatments are not well-understood. We conducted a systematic review and meta-analysis of all published studies up to March 15, 2020 which reported COVID-19 clinical features and/or treatment outcomes. 45 studies reporting 4203 patients were included. Pooled rates of intensive care unit (ICU) admission, mortality and acute respiratory distress syndrome (ARDS) were 10.9%, 4.3% and 18.4%, respectively. On meta-regression, ICU admission was predicted by raised leukocyte count (p<0.0001), raised alanine aminotransferase (p=0.024), raised aspartate transaminase (p=0.0040), elevated lactate dehydrogenase (LDH) (p<0.0001) and increased procalcitonin (p<0.0001). ARDS was predicted by elevated LDH (p<0.0001), while mortality was predicted by raised leukocyte count (p=0.0005) and elevated LDH (p<0.0001). Treatment with lopinavir-ritonavir showed no significant benefit in mortality and ARDS rates. Corticosteroids were associated with a higher rate of ARDS (p=0.0003)."],"journal":"Clin Infect Dis","authors":["Zhang, John J Y","Lee, Keng Siang","Ang, Li Wei","Leo, Yee Sin","Young, Barnaby Edward"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32407459","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1093/cid/ciaa576","keywords":["coronavirus","covid-19","risk factor","severe","treatment"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666802845499785216,"score":57.80884},{"pmid":32422233,"title":"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York.","text":["Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York.","BACKGROUND & AIMS: New York is the current epicenter of Coronavirus disease 2019 (COVID-19) pandemic. The underrepresented minorities, where the prevalence of obesity is higher, appear to be affected disproportionately. Our objectives were to assess the characteristics and early outcomes of patients hospitalized with COVID-19 in the Bronx and investigate whether obesity is associated with worse outcomes independently from age, gender and other comorbidities. METHODS: This retrospective study included the first 200 patients admitted to a tertiary medical center with COVID-19. The electronic medical records were reviewed at least three weeks after admission. The primary endpoint was in-hospital mortality. RESULTS: 200 patients were included (female sex: 102, African American: 102). The median BMI was 30 kg/m(2). The median age was 64 years. Hypertension (76%), hyperlipidemia (46.2%), and diabetes (39.5%) were the three most common comorbidities. Fever (86%), cough (76.5%), and dyspnea (68%) were the three most common symptoms. 24% died during hospitalization (BMI<25 kg/m(2): 31.6%, BMI 25-34 kg/m(2): 17.2%, BMI>/=35 kg/m(2): 34.8%, p= 0.03). Increasing age (analyzed in quartiles), male sex, BMI>/=35 kg/m(2) (reference: BMI 25-34 kg/m(2)), heart failure, CAD, and CKD or ESRD were found to have a significant univariate association with mortality. The multivariate analysis demonstrated that BMI>/=35 kg/m(2) (reference: BMI 25-34 kg/m(2), OR: 3.78; 95% CI: 1.45 - 9.83; p=0.006), male sex (OR: 2.74; 95% CI: 1.25 - 5.98; p=0.011) and increasing age (analyzed in quartiles, OR: 1.73; 95% CI: 1.13 - 2.63; p=0.011) were independently associated with higher in-hospital mortality. Similarly, age, male sex, BMI>/=35 kg/m(2) and current or prior smoking were significant predictors for increasing oxygenation requirements in the multivariate analysis, while male sex, age and BMI>/=35 kg/m(2) were significant predictors in the multivariate analysis for the outcome of intubation. CONCLUSIONS: In this cohort of hospitalized patients with COVID-19 in a minority-predominant population, severe obesity, increasing age, and male sex were independently associated with higher in-hospital mortality and in general worse in-hospital outcomes.","Metabolism","Palaiodimos, Leonidas","Kokkinidis, Damianos G","Li, Weijia","Karamanis, Dimitrios","Ognibene, Jennifer","Arora, Shitij","Southern, William N","Mantzoros, Christos S","32422233"],"abstract":["BACKGROUND & AIMS: New York is the current epicenter of Coronavirus disease 2019 (COVID-19) pandemic. The underrepresented minorities, where the prevalence of obesity is higher, appear to be affected disproportionately. Our objectives were to assess the characteristics and early outcomes of patients hospitalized with COVID-19 in the Bronx and investigate whether obesity is associated with worse outcomes independently from age, gender and other comorbidities. METHODS: This retrospective study included the first 200 patients admitted to a tertiary medical center with COVID-19. The electronic medical records were reviewed at least three weeks after admission. The primary endpoint was in-hospital mortality. RESULTS: 200 patients were included (female sex: 102, African American: 102). The median BMI was 30 kg/m(2). The median age was 64 years. Hypertension (76%), hyperlipidemia (46.2%), and diabetes (39.5%) were the three most common comorbidities. Fever (86%), cough (76.5%), and dyspnea (68%) were the three most common symptoms. 24% died during hospitalization (BMI<25 kg/m(2): 31.6%, BMI 25-34 kg/m(2): 17.2%, BMI>/=35 kg/m(2): 34.8%, p= 0.03). Increasing age (analyzed in quartiles), male sex, BMI>/=35 kg/m(2) (reference: BMI 25-34 kg/m(2)), heart failure, CAD, and CKD or ESRD were found to have a significant univariate association with mortality. The multivariate analysis demonstrated that BMI>/=35 kg/m(2) (reference: BMI 25-34 kg/m(2), OR: 3.78; 95% CI: 1.45 - 9.83; p=0.006), male sex (OR: 2.74; 95% CI: 1.25 - 5.98; p=0.011) and increasing age (analyzed in quartiles, OR: 1.73; 95% CI: 1.13 - 2.63; p=0.011) were independently associated with higher in-hospital mortality. Similarly, age, male sex, BMI>/=35 kg/m(2) and current or prior smoking were significant predictors for increasing oxygenation requirements in the multivariate analysis, while male sex, age and BMI>/=35 kg/m(2) were significant predictors in the multivariate analysis for the outcome of intubation. CONCLUSIONS: In this cohort of hospitalized patients with COVID-19 in a minority-predominant population, severe obesity, increasing age, and male sex were independently associated with higher in-hospital mortality and in general worse in-hospital outcomes."],"journal":"Metabolism","authors":["Palaiodimos, Leonidas","Kokkinidis, Damianos G","Li, Weijia","Karamanis, Dimitrios","Ognibene, Jennifer","Arora, Shitij","Southern, William N","Mantzoros, Christos S"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32422233","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.metabol.2020.154262","keywords":["bronx","covid-19","new york","sars-cov-2","coronavirus","mortality","obesity","pandemic","risk factor"],"locations":["New York","Bronx","African American","hyperlipidemia","Bronx","New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667159284600799232,"score":55.19441}]}